OHSU

Clinical Trials

Clinical trials are the final step in a long process of research. They allow scientists to test the value of their research to diagnose, treat and prevent diseases and disabilities.  

Each clinical trial is an opportunity to test a promising new invention or treatment in humans for the first time.

Clinical trials for people with pituitary disorders include:  

A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease (Study completed)
Dr. Maria Fleseriu was the principal investigator at OHSU.

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome (invitation only)
Dr. Maria Fleseriu is the principal investigator at OHSU.

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Dr. Maria Fleseriu is the principal investigator at OHSU. Interested patients should call the Clinical Trials Coordinator at 503 494.9546.

Safety and Efficacy of LCI699 in Cushing's Disease Patients
Dr. Maria Fleseriu is the principal investigator at OHSU. Interested patients should call the Clinical Trials Coordinator at 503 494.9546.


Participating in Clinical Trials at the OHSU Northwest Pituitary Center

If you are interested in participating in a clinical trial, you can find more information at the OHSU Study Participation Web site. 

You can also call:
Neurological Surgery Clinical Trials Coordinator
503 494-9546


Clinical Trials at OHSU

Oregon Health & Science University requires all investigators that are conducting human subjects' research to respect and protect the rights and welfare of participants recruited for, and/or participating in, research under the supervision of OHSU. As part of this commitment, Responsible Conduct of Research education is required of all investigators, research staff, and other relevant personnel.

All clinical research undertaken at OHSU is subject to approval by the institutional review board (IRB).
The institutional review board is a group that has been formally designated to approve, monitor, and review biomedical and behavioral research involving humans with the aim of protecting the rights and welfare of the subjects. The IRB approves, requires modifications to, or disapproves clinical research. The IRB performs critical oversight functions for research conducted on human subjects that are scientific, ethical, and regulatory.

OHSU Research Integrity Office

For more information about clinical trials and a nationwide database of clinical trials, please go to the U.S. National Institutes of Health clinical trials Web site